ArticleKidney3602020

Anti-Cancer Activity of PAK4/NAMPT Inhibitor and Programmed Cell Death Protein-1 Antibody in Kidney Cancer.

Josephine F Trott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.